Our History
Acino established itself in Latin America with the acquisition of MEPHA in 2011 and significantly expanded its business in December 2023 with the acquisition of M8 Pharmaceuticals. This transformative milestone boosted Acino’s presence in Latin America and significantly diversified its product portfolio thanks to M8’s proven licensing platform.
Following the acquisition of M8, a broader LATAM region was established, now comprising Mexico, Brazil, and Candean (Ecuador, Central America, and the Caribbean).
Acino LATAM faces a fantastic opportunity to continue building a great corporate culture, attract top talent to support new businesses, and work to expand health and wellness in Latin America through an exceptional and innovative portfolio.
Acino’s Latin American headquarters are located in Mexico City, with offices in Panama City and Sao Paulo, Brazil.
1836
Foundation of “Schweizerhall” near Basel
2008
Change of name of the group and its subsidiaries to Acino.
2011
Acino enters Latin America with the acquisition of MEPHA, marking the beginning of its presence in the region
2021
ADQ, based in Abu Dhabi, one of the largest holding companies in the region with a broad portfolio of major companies spanning key sectors, signs an agreement to acquire Acino
2023
Launch of Arcera and establishment of new corporate offices
December 2023
Significant expansion in LATAM with the acquisition of M8 Pharmaceuticals, strengthening capabilities and diversifying the portfolio
April 2024
Mexico City is designated as the new center of operations in Latin America
December 2024
Transition of Arcera to a single organization as “One Arcera”
2025 and beyond
We continue to build a strong corporate culture, attract talent, and develop an innovative portfolio to promote health and well-being in Latin America